This article is more than 5 years old. Information may no longer be current.
Cardiology Today's Intervention top 5 stories from ISET
Click Here to Manage Email Alerts
Cardiology Today’s Intervention recently reported live from the International Symposium on Endovascular Therapy in Hollywood, Fla. We have compiled a list of the five most popular articles from this meeting on Healio.com/Intervention.
Cardiology Today’s Intervention readers were most interested in new oral anticoagulants in patients with venous thromboembolism, reimbursement for carotid stenting, critical limb ischemia, vascular stents for treatment of long lesions, and much more.
Evidence on safety, efficacy of newer oral anticoagulants in patients with VTE continues to mount
In patients with VTE, treatment with non-vitamin K oral anticoagulants is safer than warfarin without compromising efficacy, Ian Del Conde, MD, FACC, section head of vascular medicine at Miami Cardiac and Vascular Institute, said at ISET 2017. Compared with warfarin, the non-vitamin K oral anticoagulants have lower rates of major bleeding in patients with VTE, and are more convenient because treatment does not require routine monitoring. Read More
Experts debate reimbursement, accreditation for carotid stenting
Foot-dragging by CMS and disagreements among professional societies are the most common reasons cited for why reimbursement for carotid stenting is limited in the United States, but there are more factors in play, according to a panel discussion at ISET 2017. Turf wars between vascular surgeons, neurologists and interventional cardiologists and radiologists have played a role in restricting reimbursement for carotid stenting in patients with carotid stenosis. Read More
Aggressive treatment to prevent amputation important for CLI
The strong association between amputation and mortality in patients with critical limb ischemia means that patients must be treated aggressively to prevent amputation, Jihad A. Mustapha, MD, FACC, FSCAI, said during a presentation. CLI affects 1 million Medicare-eligible patients per year at an estimated annual cost of $3 billion, and 25% of patients receive amputation as a first-line treatment. Read More
Vascular stent safe, effective in challenging long lesions
In a study presented at ISET 2017, the Tigris Vascular Stent (W.L. Gore and Associates) demonstrated safety and efficacy at 2 years, with no evidence of stent fracture, in patients with symptomatic peripheral artery disease with long atherosclerotic lesions in the superficial femoral or proximal popliteal arteries. Read More
Risk stratification essential for acute PE
The presentation of acute pulmonary embolism varies, and risk stratification of patients is essential to achieve optimal outcomes, a speaker said at ISET 2017.